|

Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer

RECRUITINGSponsored by Institute of Oncology Ljubljana
Actively Recruiting
SponsorInstitute of Oncology Ljubljana
Started2019-11-01
Est. completion2026-12-31
Eligibility
Age18 Years – 75 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06648148

Summary

The purpose of this study is to identify potential genetic and other molecular biomarkers of response to radiation therapy in breast cancer that may help to personalize breast cancer radiation treatment in the future.

Eligibility

Age: 18 Years – 75 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Breast cancer patients with DCIS with an indication for adjuvant radiation therapy

Exclusion Criteria:

* Any specific systemic oncological therapy

Conditions3

Breast CancerCancerRadiotherapy Side Effect

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.